In March 2026, Quillaja Green Biosolutions joined the global immunology community at the World Vaccine Congress in Washington D.C. Our participation focused on the evolving demand for high-purity saponin matrices and the critical role of secure, scalable supply chains for next-generation adjuvants.
Engagement with key industry stakeholders reaffirmed that the future of vaccine R&D depends on the precise bridge between botanical integrity and clinical-grade isolation. For QGB, this congress was a milestone in aligning our upstream processing with the rigorous expectations of the global biotech sector.
#WorldVaccineCongress #WVC2026 #WashingtonDC #VaccineInnovation #Networking #GlobalHealth #QGBinDC